- Home
- CLPT vs BCYC Comparison
CLPT vs BCYC Comparison
Compare CLPT & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPT | BCYC |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 456.4M |
| IPO Year | 2009 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CLPT | BCYC |
|---|---|---|
| Price | $13.99 | $5.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $26.50 | $19.10 |
| AVG Volume (30 Days) | ★ 532.2K | 451.8K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.22 | ★ 42.91 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,390,000.00 | N/A |
| Revenue This Year | $18.93 | N/A |
| Revenue Next Year | $51.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.04 | N/A |
| 52 Week Low | $9.76 | $5.03 |
| 52 Week High | $30.10 | $11.12 |
Technical Indicators
Market Signals| Indicator | CLPT | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 43.79 |
| Support Level | $13.38 | $5.03 |
| Resistance Level | $14.86 | $7.14 |
| Average True Range (ATR) | 0.94 | 0.31 |
| MACD | 0.16 | 0.05 |
| Stochastic Oscillator | 64.04 | 64.13 |
Price Performance
Historical ComparisonAbout CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.